Nicotine Polacrilex Lozenge
Product Images NDC 45802-344

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex (NDC 45802-344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Perrigo Nicotine Polacrilex Image 1 (01 31 17 344b9rtc4 Image 1)

Packaging label for Perrigo Nicotine Polacrilex Lozenges 2 mg, mint flavor, intended as a stop smoking aid. The label states it contains 72 lozenges (3 QuitTube containers of 24 each) and includes usage instructions related to smoking timing. The design shows the green Perrigo logo, a visual of the white lozenge, and a blue QuitTube container image with a safety warning regarding the printed seal under the cap.*

FDA Label Image

Perrigo Nicotine Polacrilex Image 2 (01 31 17 344b9rtc4 Image 2)

Nicotine Polacrilex 2 mg lozenge packaging label shows Drug Facts, including active ingredient and uses to reduce withdrawal symptoms from quitting smoking. The label includes warnings, directions for use, inactive ingredients, and manufacturer information, Perrigo, Allegan, MI. It highlights age restrictions and storage instructions, with a barcode and lot/expiration placeholders.*

FDA Label Image

Wallet_card (Image 01)

An informational wallet card providing contact phone numbers for quitting help, listing the American Lung Association, American Cancer Society, and American Heart Association. It also suggests contacting a quitting buddy or friend who has quit smoking.*

FDA Label Image

Wallet‑_card (Image 02)

An instructional wallet card with the heading "My most important reasons to quit smoking are:" followed by six blank lines for personal entries. The card is bordered and designed for individuals to write motivational reasons to stop smoking.*

FDA Label Image

Smoke_free_logo (Image 03)

FDA Label Image

Upc_example (Image 04)

Nicotine Polacrilex 2 mg lozenge by Padagis Israel Pharmaceuticals Ltd. The image shows a close-up of a barcode with the text 'EXAMPLE UPC ONLY' printed above it in red, and the UPC number below.*

FDA Label Image

Stickers (Image 05)

An instructional diagram with four colored boxed reminders for using Nicotine Polacrilex lozenges, detailing the recommended frequency of lozenge use at different time points: Step 1 at week 1 (1 lozenge every 1 to 2 hours), Step 2 at week 7 (1 lozenge every 2 to 4 hours), Step 3 at week 10 (1 lozenge every 4 to 8 hours), and an 'EX-SMOKER' mark 12 weeks after the quit date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.